1. Favorable prognostic impact of RAS mutation status in multiple myeloma treated with high-dose melphalan and autologous stem cell support in the era of novel agents: a single center perspective. Issue 1 (2nd January 2016) Authors: Gebauer, Niklas; Biersack, Harald; Czerwinska, Ann-Cathrin; Schemme, Janina; Hardel, Tim Tristan; Bernard, Veronica; Rades, Dirk; Lehnert, Hendrik; Luley, Kim Barbara; Thorns, Christoph Journal: Leukemia & lymphoma Issue: Volume 57:Issue 1(2016:Jan.) Page Start: 226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Prevalence of targetable oncogenic mutations and genomic alterations in Epstein–Barr virus-associated diffuse large B-cell lymphoma of the elderly. Issue 4 (April 2015) Authors: Gebauer, Niklas; Gebauer, Judith; Hardel, Tim Tristan; Bernard, Veronica; Biersack, Harald; Lehnert, Hendrik; Rades, Dirk; Feller, Alfred Christian; Thorns, Christoph Journal: Leukemia & lymphoma Issue: Volume 56:Issue 4(2015:Apr.) Page Start: 1100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Single nucleotide polymorphisms in TP53 but not KRAS or MDM2 are predictive of clinical outcome in multiple myeloma treated with high-dose melphalan and autologous stem cell support. Issue 6 (2nd June 2016) Authors: Gebauer, Niklas; Biersack, Harald; Czerwinska, Ann-Cathrin; Schemme, Janina; Hardel, Tim Tristan; Bernard, Veronica; Rades, Dirk; Lehnert, Hendrik; Luley, Kim Barbara; Thorns, Christoph Journal: Leukemia & lymphoma Issue: Volume 57:Issue 6(2016:Jun.) Page Start: 1482 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗